---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-007190"
form_type: "8-K"
ticker: "FBRX"
cik: "0001419041"
company_name: "Forte Biosciences, Inc."
filed_at: "2023-01-12T23:59:59+00:00"
generated_at: "2026-06-20T15:56:55.770502+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Forte Biosciences appoints David Gryska to board; Patricia Walker resigns

## Summary
- David Gryska appointed as Class II director effective January 10, 2023; serves on Audit Committee.
- Gryska is former CFO/Exec VP of Incyte and Celgene; receives 50,000 stock option vesting over 3 years.
- Patricia Walker resigned from board and all committees effective January 6, 2023; no disagreement cited.
- Gryska will receive $40,000/year as director plus $8,000/year for Audit Committee service.

## SEC filing metadata
- accession: 0001193125-23-007190
- form_type: 8-K
- ticker: FBRX
- cik: 0001419041
- company_name: Forte Biosciences, Inc.
- filed_at: 2023-01-12T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1419041/000119312523007190/0001193125-23-007190-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1419041/000119312523007190/d447019d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-007190
- JSON: https://secwatch.observer/filing/0001193125-23-007190.json
- Plain text: https://secwatch.observer/filing/0001193125-23-007190.txt

## Key facts
- Executive change
  David Gryska was appointed as Director at Forte Biosciences, Inc..
  - Action: appointed
  - Role: Director
  source text: On January 10, 2023, the Board of Directors (the “Board) of the Company, upon recommendation of the Nominating and Governance Committee of the Board, appointed David Gryska, M.B.A. to the Board to fill a vacancy on the Board, effective January 10, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1419041/000119312523007190/0001193125-23-007190-index.htm
- Executive change
  Patricia Walker resigned as Director at Forte Biosciences, Inc..
  - Action: resigned
  - Role: Director
  source text: On January 6, 2023, Patricia Walker, M.D., Ph.D. notified Forte Biosciences, Inc. (the “Company”) of her resignation as a member of the Board of Directors (the “Board”) of the Company and from all committees of the Board on which she served, in each case effective as of January 6, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1419041/000119312523007190/0001193125-23-007190-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.